Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats

Biochimie ◽  
2007 ◽  
Vol 89 (3) ◽  
pp. 393-402 ◽  
Author(s):  
Abdul R. Asif ◽  
Victor W. Armstrong ◽  
Antje Voland ◽  
Eberhard Wieland ◽  
Michael Oellerich ◽  
...  
2010 ◽  
Vol 43 (1-2) ◽  
pp. 208-213 ◽  
Author(s):  
Horst Feichtiger ◽  
Eberhard Wieland ◽  
Victor W. Armstrong ◽  
Maria Shipkova

2000 ◽  
Vol 46 (3) ◽  
pp. 365-372 ◽  
Author(s):  
Maria Shipkova ◽  
Ekkehard Schütz ◽  
Victor William Armstrong ◽  
Paul Dieter Niedmann ◽  
Michael Oellerich ◽  
...  

Abstract Background: The acyl glucuronide (AcMPAG) of mycophenolic acid (MPA) has been found to possess pharmacologic and potentially proinflammatory activity in vitro. To establish its pharmacologic and toxicologic relevance in vivo, a reversed-phase HPLC method was modified to simultaneously determine MPA, the phenolic MPA-glucuronide (7-O-MPAG), and AcMPAG. In addition, cross-reactivity of AcMPAG in the Emit assay for MPA was investigated. Methods: The procedure used simple sample preparation, separation with a Zorbax Eclipse-XDB-C8 column, and gradient elution. AcMPAG was quantified as 7-O-MPAG-equivalents. Results: The assay was linear up to 50 mg/L for MPA, 250 mg/L for 7-O-MPAG, and 10 mg/L for AcMPAG (r >0.999). Detection limits were 0.01, 0.03, and 0.04 mg/L for MPA, 7-O-MPAG, and AcMPAG, respectively. The recoveries were 99–103% for MPA, 95–103% for 7-O-MPAG, and 104–107% for AcMPAG. The within-day imprecision was <5.0% for MPA (0.2–25 mg/L), <4.4% for 7-O-MPAG (10–250 mg/L), and ≤14% for AcMPAG (0.1–5 mg/L). The between-day imprecision was <6.2%, <4.5%, and ≤14% for MPA, 7-O-MPAG, and AcMPAG, respectively. When isolated from microsomes, purified AcMPAG (1–10 mg/L) revealed a concentration-dependent cross-reactivity in an Emit assay for the determination of MPA ranging from 135% to 185%. This is in accordance with the bias between HPLC and Emit calculated in 270 samples from kidney transplant recipients receiving mycophenolate mofetil therapy, which was greater (median, 151.2%) than the respective AcMPAG concentrations determined by HPLC. AcMPAG was found to undergo hydrolysis when samples were stored up to 24 h at room temperature or up to 30 days at 4 °C or −20 °C. Acidified samples (pH 2.5) were stable up to 30 days at −20 °C. Conclusions: The HPLC and Emit methods for AcMPAG described here may allow investigation of its relevance for the immunosuppression and side effects associated with mycophenolate mofetil therapy.


2001 ◽  
Vol 33 (1-2) ◽  
pp. 1080-1081 ◽  
Author(s):  
M Shipkova ◽  
E Wieland ◽  
E Schütz ◽  
C Wiese ◽  
P.D Niedmann ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document